Arcutis Biotherapeutics Reports Inducement Grants Under

WESTLAKE VILLAGE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical...

Related Keywords

Amanda Sheldon ,Exchange Commission ,Twitter ,Facebook ,Head Of Corporate Communications ,Nasdaq ,Compensation Committee Of Arcuti Board Directors ,Arcutis Biotherapeutics Inc ,Compensation Committee ,Arcuti Board ,Nasdaq Listing Rule ,Nasdaq Arqt ,Arcutis Biotherapeutics ,Nc ,